Charlotte Barttelot
About Charlotte Barttelot
Charlotte Barttelot is a Principal at MMC Ventures and serves as a board member for several companies, including Wawa Fertility and Sano Genetics. With over ten years of experience in investment, she specializes in data-driven health investments and has a background in pharmacology and neuroscience.
Work at MMC Ventures
Charlotte Barttelot serves as a Principal at MMC Ventures, a position she has held since 2022. In this role, she focuses on data-driven health investments, leveraging her expertise in emerging technologies within the European health and life sciences sectors. Her responsibilities include identifying and supporting high-growth technology companies, particularly in health-related fields.
Current Board Memberships
Charlotte Barttelot holds several board member positions across various organizations. She has been a board member at Wawa Fertility since 2024, Multiomic Health since 2023, ImVitro since 2022, Sano Genetics since 2022, XUND since 2022, and Captur since 2022. In these roles, she contributes her knowledge in investment and data infrastructure to guide strategic decisions.
Previous Work Experience
Charlotte Barttelot has a diverse professional background in investment management. She worked at Mercia Asset Management PLC as an Investment Manager from 2020 to 2021 and as an Investment Associate for six months in 2020. Prior to that, she spent three years at Silicon Valley Bank, where she held the positions of Senior Associate and Vice President from 2013 to 2018. Additionally, she worked at NVM Private Equity LLP as an Investment Associate from 2018 to 2020.
Education and Expertise
Charlotte Barttelot earned her Master's degree in Finance from London Business School, studying from 2016 to 2018. She also holds a Bachelor of Science (BSc) in Biological Sciences with Honours in Pharmacology from The University of Edinburgh, which she completed from 2008 to 2012. Her educational background in pharmacology and neuroscience informs her investment strategies, particularly in health and life sciences.
Investment Focus and Specialization
Charlotte Barttelot specializes in data infrastructure and data science within her investment focus. She emphasizes the application of emerging technologies in sectors such as European health, life sciences, insurtech, and B2B enterprise software. With over ten years of experience, she has a proven track record in backing high-growth technology companies across multiple sectors.